Ro

[Ro @roinvests]

@Divergent7651 9m in cash only gets you 4% of the company at this price. I think they save the leverage for an acquisition. My read was they have more than one target and they walked from this particular one.

[Finsee @Finsee_main]

$ISSC Q3 2026 earnings: Commercial Strength and Margin Resilience Outshine Tough Comps

Innovative Aerosystems (transitioning ticker to 'IA') delivered an impressive Q3, shaking off the much-telegraphed F-16 program headwind. Despite lapping a massive F-16 revenue pull-forward in the prior-year quarter, the company grew total sales by 10.7% to $26.7M, powered by robust organic demand in commercial and business aviation. Crucially, gross margins defied previous management warnings: after guiding for margins to normalize in the 'mid-40s' in prior quarters, Q3 margins held strong at 51.7%. The resulting operating leverage drove Adjusted EBITDA up 74.7% YoY, highlighting the cash-generative power of the company's capital-light model.

Full article with charts - link in bio

🐂 𝐁𝐮𝐥𝐥 𝐂𝐚𝐬𝐞
• 𝐌𝐚𝐫𝐠𝐢𝐧 𝐂𝐨𝐧𝐭𝐫𝐚𝐝𝐢𝐜𝐭𝐢𝐨𝐧 𝐢𝐬 𝐚 𝐁𝐮𝐥𝐥𝐢𝐬𝐡 𝐒𝐮𝐫𝐩𝐫𝐢𝐬𝐞 — Management had repeatedly cautioned that gross margins would normalize to the mid-40% range as military mix increased. Instead, favorable commercial aftermarket mix and pricing power held Q3 margins at 51.7%, vastly outperforming expectations.
• 𝐅𝐫𝐞𝐞 𝐂𝐚𝐬𝐡 𝐅𝐥𝐨𝐰 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 — The company generated $12.3M in FCF over the last nine months (up 155% YoY), demonstrating that the recent heavy capital expenditures for the Exton facility expansion are now in the rearview mirror.

🐻 𝐁𝐞𝐚𝐫 𝐂𝐚𝐬𝐞
• 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐄𝐱𝐩𝐞𝐧𝐬𝐞𝐬 𝐒𝐮𝐫𝐠𝐢𝐧𝐠 — Total operating expenses spiked 53% YoY to $7.8M in Q3. While framed as R&D and business development investments, this aggressive spend rate risks eating into the gross margin gains if top-line growth decelerates.
• 𝐁𝐚𝐜𝐤𝐥𝐨𝐠 𝐒𝐡𝐨𝐰𝐢𝐧𝐠 𝐒𝐞𝐪𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐅𝐚𝐭𝐢𝐠𝐮𝐞 — Backlog contracted from $87.0M in Q2 to $82.9M in Q3. While still up YoY, the sequential dip suggests new order velocity may be struggling to keep pace with the accelerated production output.

⚖️ 𝐕𝐞𝐫𝐝𝐢𝐜𝐭: 🟢
Bullish. Absorbing the painful Q3 25 F-16 comparison and still printing 11% top-line growth is a testament to the underlying commercial business. Sustaining >50% gross margins fundamentally alters the profitability trajectory of the company.

𝐊𝐞𝐲 𝐓𝐡𝐞𝐦𝐞𝐬

🟢 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐚𝐧𝐝 𝐁𝐢𝐳𝐀𝐯 𝐎𝐟𝐟𝐬𝐞𝐭𝐭𝐢𝐧𝐠 𝐌𝐢𝐥𝐢𝐭𝐚𝐫𝐲 𝐋𝐮𝐦𝐩𝐢𝐧𝐞𝐬𝐬
The core organic growth engine fired on all cylinders this quarter. Despite explicit warnings in Q1 and Q2 that FY26 organic growth would be 'essentially flat' due to the F-16 comps, the strength of the commercial aftermarket and business aviation sectors drove an overall 10.7% revenue beat. This diversification proves the business is not a one-trick military pony.

🟢 𝐋𝐢𝐛𝐞𝐫𝐭𝐲 𝐅𝐥𝐢𝐠𝐡𝐭 𝐃𝐞𝐜𝐤 𝐖𝐢𝐧𝐬 𝐞𝐕𝐓𝐎𝐋 𝐕𝐚𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 [NEW]
In a major validation of its internal R&D, the company secured its first production award for the Liberty Flight Deck platform from a leading Japanese developer of electric vertical takeoff and landing (eVTOL) aircraft. This transitions the technology from a conceptual 'autonomous flight' investment into a tangible, commercialized product line.

🟢 𝐀𝐲𝐝𝐢𝐧 𝐃𝐢𝐬𝐩𝐥𝐚𝐲𝐬 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧 𝐄𝐱𝐩𝐚𝐧𝐝𝐬 𝐃𝐞𝐟𝐞𝐧𝐬𝐞 𝐑𝐞𝐚𝐜𝐡 [NEW]
Closed in July 2026, the acquisition of Aydin Displays adds complementary technology to the portfolio. Crucially, it expands the company's addressable market beyond aerospace into naval and ground defense sectors, aligning perfectly with the macro tailwind of elevated global defense budgets.

🔴 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐄𝐱𝐩𝐞𝐧𝐬𝐞𝐬 𝐄𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐌𝐚𝐫𝐠𝐢𝐧 𝐁𝐞𝐚𝐭 [NEW]
While gross profit expanded by a massive 60.9% YoY, operating expenses kept an aggressive pace, rising from $5.1M to $7.8M (a 53% increase). SG&A alone climbed from $4.1M to $5.9M. The company attributes this to R&D, business development, and M&A integration, but this level of overhead expansion requires sustained double-digit revenue growth to justify.

🔴 𝐒𝐞𝐪𝐮𝐞𝐧𝐭𝐢𝐚𝐥 𝐁𝐚𝐜𝐤𝐥𝐨𝐠 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭𝐢𝐨𝐧
Backlog ended Q3 at $82.9M. While this is an improvement from the $72.4M reported a year ago, it represents a notable $4.1M sequential decline from Q2's $87.0M mark. The decline indicates that the company burned through backlog faster than it replenished it this quarter ($26.7M in revenue vs $22.7M in new orders).

⚪ 𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐛𝐭 𝐋𝐞𝐯𝐞𝐥𝐬 𝐚𝐧𝐝 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧 𝐑𝐢𝐬𝐤
Net debt has swollen to $43.8M, up $21M from the year-ago period, reflecting aggressive capital deployment (>$35M) for acquisitions and the Exton facility. While the leverage ratio remains manageable at 1.4x Adjusted EBITDA, the rapid integration of Moog STEC, Honeywell product lines, and now Aydin Displays carries significant execution risk for a company of this size.

𝐎𝐭𝐡𝐞𝐫 𝐊𝐏𝐈𝐬

𝐀𝐝𝐣𝐮𝐬𝐭𝐞𝐝 𝐄𝐁𝐈𝐓𝐃𝐀 (𝟐𝟔𝐐𝟑): $7.7 million
Accelerating significantly. Adjusted EBITDA surged 74.7% from $4.4 million in the prior-year period. This represents an Adjusted EBITDA margin of roughly 28.8%, aligning perfectly with the company's long-term 'IA NEXT' strategy target of 25% to 30%.

𝐅𝐫𝐞𝐞 𝐂𝐚𝐬𝐡 𝐅𝐥𝐨𝐰 (𝟗 𝐌𝐨𝐧𝐭𝐡𝐬 𝐘𝐓𝐃): $12.3 million
Accelerating. Up sharply from $4.8 million in the prior-year period (+155%). This explosion in free cash flow generation validates the company's capital-light model now that the heavy lifting on the Exton facility capital expenditures ($3.2M vs $5.5M last year) is largely complete.

𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞

𝐅𝐘𝟐𝟎𝟐𝟔 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤: Positive finish expected
Management did not provide short-form numeric guidance in the press release but stated they expect to finish fiscal 2026 on a 'positive note' driven by commercial, business jet, and military markets. This effectively overrides the highly cautious 'essentially flat' organic growth rhetoric given during the Q1 and Q2 calls.

𝐊𝐞𝐲 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬

𝐌𝐚𝐫𝐠𝐢𝐧 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲
You previously guided to the mid-40s for gross margins, yet printed 51.7% this quarter. Was this purely driven by aftermarket mix, or have the F-16 production efficiencies at Exton improved faster than anticipated? Can we underwrite a 50%+ profile going forward?

𝐀𝐲𝐝𝐢𝐧 𝐃𝐢𝐬𝐩𝐥𝐚𝐲𝐬 𝐂𝐨𝐧𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧
With the Aydin Displays acquisition closing in July, what should we model for their revenue and margin contribution in Q4, and what specific naval/ground defense cross-selling opportunities are immediately actionable?

𝐎𝐩𝐄𝐱 𝐑𝐮𝐧-𝐑𝐚𝐭𝐞
Operating expenses jumped to $7.8M in the quarter. How much of the sequential and YoY increase is tied to one-time M&A integration costs versus a permanent step-up in base R&D and SG&A required to support the $250M long-term revenue target?

𝐞𝐕𝐓𝐎𝐋 𝐌𝐚𝐫𝐤𝐞𝐭 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬
The Liberty Flight Deck award from the Japanese eVTOL developer is a major milestone. What does the development revenue and long-term production economics look like for this specific contract?

[Ro @roinvests]

@onecentinvest I believe they did say the programs they’re putting will improve performance next few quarters. Would have been better to quantify impact atleast provide a range. That being said they could have easily juiced the stock by going ahead with bad m&a but didn’t so props there $cph.to

[Ro @roinvests]

@SigmondThegrey @onecentinvest Disturbing thought. Real skin in the game.

[Ro @roinvests]

@ValueHunter7 @SigmondThegrey @ragingbullcap Agreed commercial channel execution needs to prove itself over next few quarters

[Ro @roinvests]

@ValueHunter7 @SmallCapNorth $cph.to Market overreacting here. Clearly Medicaid policy changes tanked covered lives and natroba was a bystander. Mgmt been putting mitigations in place to grow commercial channel. Natroba likely stabilizes at this level. We likely see Epuris expansion and m&a over 3-6 mos.

[Ro @roinvests]

@ValueHunter7 @SmallCapNorth Walmart solves stockouts not Medicaid coverage. Just a guess - natroba was concentrated in few managed care plans that tightened approvals. Over the long term it’s crucial to get additional states to diversify that exposure $cph.to

[Ro @roinvests]

$Smti unfortunate they accepted a lowball bid. Large insider ownership can cut both ways without proper governance. Right when operating leverage starting to show up this should have compounded and multi bagged for years.

[Ro @roinvests]

@VikingVan100 Thanks as always! Any thoughts on international Peter mentioned 8% growth but adjusted for favorable development CR was over 100%?

[Ro @roinvests]

$Issc yet another acquisition in the bag paying around 1.5x sales vertically integrated military display manufacturer. Cross sell opportunity is huge creating lock in dynamics once they sell a full avionics suite to a platform https://t.co/K0FUYqaCKo

[Ro @roinvests]

@UCompounders That’s a lot of conviction. It’s a 10% position for me would buy more closer to $10-12. Long term great prospects I think their $250M by 2030 is doable.

[Ro @roinvests]

Happy 4th! Free speech and free enterprise - something we highly underestimate until you travel elsewhere. Despite all the problems still an amazing place to live in!

[Ro @roinvests]

@UCompounders Summarizes it really well. Had looked at this but went in my too hard pile. Management has really executed well but too much dependence on screen expansion and box office traffic. Not exactly one foot hurdle.

[Undiscovered Compounders @UCompounders]

Their strategy has clearly been to divest. As early as 2023, in $ISSC 's conference calls, the CEO was saying that Honeywell was divesting a significant number of lines but wouldn't say why.

Three years later and a spin-off down the road, the question of a trend reversal is viable, but I don't think that's the case. Honeywell still holds a large number of lines. And despite the "destocking," I think there are still quite a few left that don't fit with $HONA. Especially now that its margins will be scrutinized by shareholders and analysts, whereas before it could bury all of that in the parent's P&L.

I could be wrong and they've already sold what they wanted to sell. I could also be right but none of the remaining lines would directly concern ISSC. Either way, it's not that serious.

There are still 5-6 aviation giants that regularly sell off lines. The latest acquisition was actually done with $MOG.A . And even if that pipeline is also limited, ISSC can acquire smaller companies.

Here is a map of the aviation sector. In the "other" category, there are literally hundreds of companies, a good portion of them significantly smaller than ISSC.

For what it's worth, at no point in the conference calls did management hint at or even signal that the supply of new lines could be a problem. According to them, it's pricing and cross-selling opportunities that are the limiting factors.

[Sergio @sergioconcepcn]

Pure asymmetry in $SMTI Surgical biz growing 19% at 93% gross margins. GAAP profitable despite 13%+ legacy debt. Refinancing = instant EPS unlock. OsStic FDA = unpriced revenue catalyst. Trading at 1.5x Sales vs. 3–6x peers. 2–3X from here

[Innovative Aerosystems @ISS_Aviation]

Innovative Aerosystems (Nasdaq: ISSC) was added as a member of the broad-market Russell 3000® Index, effective June 29th as part of the Russell indexes semi-annual reconstitution. #RussellRecon

https://t.co/T6gwihPFQS

[Ro @roinvests]

@BetterIRR Economy is in the gutter drivers dropping coverage, my guess is soft market will fix this. Structural concern is they lost part of $pgr business to RA global + autonomous will in the long run reduce total loss rates even if it spikes in the short term

[Ro @roinvests]

@YellowCatCap Exactly, never got comfortable with this one considering long term economics of underlying businesses is in decline. This is the worst kind of business model that relies on debt or equity raises to keep the party going